Terminated NA INTERVENTIONAL 3-arm NCT03004885

Enhanced Lung Protective Ventilation for ARDS Patients With PrismaLung (PROVAP)

Sponsor: Hôpital Européen Marseille

Conditions Acute Respiratory Distress Syndrome

Interventions PrismaLung

Updated 6 times since 2017 Last updated: Mar 10, 2018 Started: Oct 12, 2017 Primary completion: Oct 13, 2017 Completion: Dec 20, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient CO2 removal obtained with the PrismaLung membrane oxygenator

Other terminated trials from Hôpital Européen Marseille

See all terminations from Hôpital Européen Marseille

Other Acute Respiratory Distress Syndrome trials with similar outcome

Browse all Acute Respiratory Distress Syndrome trials

A NA clinical study on Acute Respiratory Distress Syndrome, this trial is terminated or withdrawn. The trial is conducted by Hôpital Européen Marseille and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Mar 2018 — Jun 2018 [monthly]

Terminated NA

Status: Not Yet Recruiting → Terminated · Phase: PHASE3 → NA

▶ Show 1 earlier version

Jan 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hôpital Européen Marseille

Data source: Hôpital Européen Marseille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France